Both Pfizer and Allergan stocks traded higher on news of impending merger between the two pharm majors.
The healthcare sector has already witnessed deals exceeding $ 850 Billion this year, as many US based companies have bought their smaller European rivals, and shifted their head office to that of the acquired company to save on Taxes there.
This deal, however is expected to be the hargest in the sector so far, as the current market value of Allergan is itslef in excess of $113 Billion.
